SCHEMBL27889588

SCHEMBL27889588

NC(=O)c1ccc(N2CCN(Cc3cccc4cnccc34)CC2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.52
OPRK1 P41145 1/20 0.52
HTT P42858 3/20 0.48
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
PARP1 P09874 2/20 0.46
SMO Q99835 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
AOC3 Q16853 1/20 0.42
AURKA O14965 1/20 0.41
KDR P35968 1/20 0.41
AURKB Q96GD4 1/20 0.41
CACNA1B Q00975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2744175 0.84 ROCK2 (0.45) HTTGAAMAPTMEN1KMT2A
SCHEMBL27873312 0.83 OPRM1 (0.53) OPRM1OPRK1MAPTPARP1SMO
SCHEMBL2744172 0.82 HTT (0.43) HTTGAAMAPTMEN1KMT2A
SCHEMBL27889644 0.79 OPRM1 (0.70) OPRM1OPRK1MAPTPARP1SMO
SCHEMBL27873250 0.78 OPRM1 (0.63) OPRM1OPRK1SMOALDH1A1KDM4E
SCHEMBL27739911 0.76 OPRM1 (0.71) OPRM1OPRK1GAAMAPTPARP1
SCHEMBL27889571 0.75 OPRM1 (0.58) OPRM1OPRK1MAPTPARP1SMO
SCHEMBL14193918 0.74 MEN1 (0.52) HTTGAAMAPTMEN1KMT2A
SCHEMBL27739959 0.73 OPRM1 (0.57) OPRM1OPRK1SMOHRH3AOC3
SCHEMBL2828056 0.72 OPRM1 (0.60) OPRM1OPRK1GAAPARP1SMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103736094-A Methods and compositions for treating leukemia NOVARTIS AG 2014-04-23 CN disclosed
CN-102695547-A Methods and compositions for treating leukemia NOVARTIS AG 2012-09-26 CN disclosed